Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 41Triple Negative Breast Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Unilateral Breast Neoplasms 1Recurrence 1Pain 1Neoplasms 1Lymphedema 1Li-Fraumeni Syndrome 1Inflammation 1Hamartoma Syndrome, Multiple 1Cystic Fibrosis 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Breast Cancer Invasive 1Breast Cancer Female 1

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Mastectomy × Clear all
NCT07217990 2026-02-17

NoCUT-BC

Ohio State University Comprehensive Cancer Center

Phase 1/2 Not yet recruiting
84 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01234532 2022-05-03

0927GCC

University of Maryland, Baltimore

Phase 2 Terminated
5 enrolled 7 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02464774 2015-06-08

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Sun Yat-sen University

Phase NA Unknown
464 enrolled
Breast

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡